Acadia Healthcare (NASDAQ:ACHC) Reaches New 12-Month High – Still a Buy?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) shares reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $28.49 and last traded at $27.8140, with a volume of 259929 shares trading hands. The stock had previously closed at $28.15.

Analysts Set New Price Targets

ACHC has been the subject of a number of research analyst reports. Zacks Research upgraded shares of Acadia Healthcare from a “strong sell” rating to a “hold” rating in a research note on Thursday, March 5th. Leerink Partners lifted their target price on shares of Acadia Healthcare from $14.00 to $22.00 and gave the stock a “market perform” rating in a research report on Thursday, February 26th. Jefferies Financial Group reiterated a “hold” rating and set a $24.50 target price on shares of Acadia Healthcare in a research note on Monday, April 20th. Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a research note on Wednesday, January 21st. Finally, Barclays lifted their price objective on Acadia Healthcare from $14.00 to $20.00 and gave the stock an “equal weight” rating in a report on Tuesday, March 3rd. Seven analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $22.65.

Acadia Healthcare Trading Down 2.2%

The stock has a 50 day simple moving average of $23.80 and a 200-day simple moving average of $19.06. The firm has a market capitalization of $2.53 billion, a P/E ratio of -2.26, a P/E/G ratio of 9.25 and a beta of 0.71. The company has a current ratio of 1.55, a quick ratio of 1.55 and a debt-to-equity ratio of 1.27.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Wednesday, February 25th. The company reported $0.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.03 by $0.04. The business had revenue of $821.46 million during the quarter, compared to the consensus estimate of $800.10 million. Acadia Healthcare had a positive return on equity of 6.53% and a negative net margin of 33.29%.The business’s quarterly revenue was up 6.1% compared to the same quarter last year. During the same period in the previous year, the company posted $0.64 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. On average, equities research analysts forecast that Acadia Healthcare Company, Inc. will post 1.48 EPS for the current fiscal year.

Institutional Investors Weigh In On Acadia Healthcare

Large investors have recently made changes to their positions in the company. EverSource Wealth Advisors LLC grew its stake in shares of Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after purchasing an additional 497 shares during the period. Hantz Financial Services Inc. grew its stake in shares of Acadia Healthcare by 501.9% during the 3rd quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock valued at $54,000 after acquiring an additional 1,822 shares during the period. Wells Fargo & Company MN grew its stake in shares of Acadia Healthcare by 208.9% during the 4th quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after acquiring an additional 1,510 shares during the period. Quent Capital LLC bought a new position in shares of Acadia Healthcare during the 3rd quarter valued at approximately $71,000. Finally, Bayforest Capital Ltd bought a new position in shares of Acadia Healthcare during the 4th quarter valued at approximately $52,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.